{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:56:06Z","timestamp":1781844966055,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.ppat.1009283","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000}}],"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Al and Mary Agnes McQuinn"},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>The frequent overexpression of CD46 in malignant tumors has provided a basis to use vaccine-lineage measles virus (MeV) as an oncolytic virotherapy platform. However, widespread measles seropositivity limits the systemic deployment of oncolytic MeV for the treatment of metastatic neoplasia. Here, we report the development of MeV-Stealth, a modified vaccine MeV strain that exhibits oncolytic properties and escapes antimeasles antibodies <jats:italic>in vivo<\/jats:italic>. We engineered this virus using homologous envelope glycoproteins from the closely-related but serologically non-cross reactive canine distemper virus (CDV). By fusing a high-affinity CD46 specific single-chain antibody fragment (scFv) to the CDV-Hemagglutinin (H), ablating its tropism for human nectin-4 and modifying the CDV-Fusion (F) signal peptide we achieved efficient retargeting to CD46. A receptor binding affinity of ~20 nM was required to trigger CD46-dependent intercellular fusion at levels comparable to the original MeV H\/F complex and to achieve similar antitumor efficacy in myeloma and ovarian tumor-bearing mice models. In mice passively immunized with measles-immune serum, treatment of ovarian tumors with MeV-Stealth significantly increased overall survival compared with treatment with vaccine-lineage MeV. Our results show that MeV-Stealth effectively targets and lyses CD46-expressing cancer cells in mouse models of ovarian cancer and myeloma, and evades inhibition by human measles-immune serum. MeV-Stealth could therefore represent a strong alternative to current oncolytic MeV strains for treatment of measles-immune cancer patients.<\/jats:p>","DOI":"10.1371\/journal.ppat.1009283","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T19:38:07Z","timestamp":1612381087000},"page":"e1009283","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6217-9451","authenticated-orcid":true,"given":"Miguel \u00c1ngel","family":"Mu\u00f1oz-Al\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Nace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-5262","authenticated-orcid":true,"given":"Alexander","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene S.","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-6932","authenticated-orcid":true,"given":"Matthew","family":"Auton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"ppat.1009283.ref001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","article-title":"Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy","volume":"4","author":"H Rehman","year":"2016","journal-title":"J Immunother Cancer"},{"key":"ppat.1009283.ref002","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/nrdp.2016.49","article-title":"Measles","volume":"2","author":"PA Rota","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"ppat.1009283.ref003","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/PAI.0b013e31821a0be9","article-title":"CD46 Expression is an unfavorable prognostic factor in breast cancer cases","volume":"19","author":"A Maciejczyk","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"ppat.1009283.ref004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00262-004-0590-0","article-title":"Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?","volume":"54","author":"Z Madjd","year":"2005","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"ppat.1009283.ref005","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1182\/bloodadvances.2018025106","article-title":"p53 regulates CD46 expression and measles virus infection in myeloma cells","volume":"2","author":"A Lok","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"ppat.1009283.ref006","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.exphem.2006.03.002","article-title":"Oncolytic measles virus targets high CD46 expression on multiple myeloma cells","volume":"34","author":"HT Ong","year":"2006","journal-title":"Exp Hematol"},{"issue":"2","key":"ppat.1009283.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1568009617666170222125035","article-title":"Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects","volume":"18","author":"P Msaouel","year":"2018","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"ppat.1009283.ref008","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fvl-2016-0129","article-title":"Designing and building oncolytic viruses","volume":"12","author":"J Maroun","year":"2017","journal-title":"Future Virol"},{"issue":"7","key":"ppat.1009283.ref009","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of disseminated cancer after systemic oncolytic virotherapy","volume":"89","author":"SJ Russell","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"ppat.1009283.ref010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12917-016-0702-z","article-title":"Diversity of susceptible hosts in canine distemper virus infection: a systematic review and data synthesis","volume":"12","author":"M Martinez-Gutierrez","year":"2016","journal-title":"BMC Vet Res"},{"issue":"14","key":"ppat.1009283.ref011","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/JVI.75.14.6418-6427.2001","article-title":"The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity","volume":"75","author":"V von Messling","year":"2001","journal-title":"J Virol"},{"issue":"3","key":"ppat.1009283.ref012","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/JVI.69.3.1661-1668.1995","article-title":"The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis","volume":"69","author":"LB Stern","year":"1995","journal-title":"J Virol"},{"issue":"36","key":"ppat.1009283.ref013","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.vaccine.2009.05.096","article-title":"A chimeric measles virus with canine distemper envelope protects ferrets from lethal distemper challenge","volume":"27","author":"RN Rouxel","year":"2009","journal-title":"Vaccine"},{"issue":"8","key":"ppat.1009283.ref014","article-title":"Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins","volume":"11","author":"MA Munoz-Alia","year":"2019","journal-title":"Viruses"},{"key":"ppat.1009283.ref015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2015.03.035","article-title":"Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein","volume":"482","author":"X Zhang","year":"2015","journal-title":"Virology"},{"issue":"10","key":"ppat.1009283.ref016","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/mt.2011.92","article-title":"Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis","volume":"19","author":"TS Miest","year":"2011","journal-title":"Mol Ther"},{"key":"ppat.1009283.ref017","article-title":"Retargeted and Stealth Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles-Immune Patients","author":"ES Bah","year":"2020","journal-title":"Molecular Cancer Therapeutics"},{"issue":"1","key":"ppat.1009283.ref018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2012.11.011","article-title":"Dog nectin-4 is an epithelial cell receptor for canine distemper virus that facilitates virus entry and syncytia formation","volume":"436","author":"RS Noyce","year":"2013","journal-title":"Virology"},{"issue":"9","key":"ppat.1009283.ref019","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1128\/JVI.79.9.5857-5862.2005","article-title":"Nearby clusters of hemagglutinin residues sustain SLAM-dependent canine distemper virus entry in peripheral blood mononuclear cells","volume":"79","author":"V von Messling","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009283.ref020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cgt.2012.92","article-title":"Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins","volume":"20","author":"AW Hudacek","year":"2013","journal-title":"Cancer gene therapy"},{"issue":"6","key":"ppat.1009283.ref021","doi-asserted-by":"crossref","first-page":"e1005641","DOI":"10.1371\/journal.ppat.1005641","article-title":"Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment","volume":"12","author":"RR Bender","year":"2016","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1009283.ref022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nbt942","article-title":"Antibody-targeted cell fusion","volume":"22","author":"T Nakamura","year":"2004","journal-title":"Nat Biotechnol"},{"issue":"10","key":"ppat.1009283.ref023","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1128\/JVI.76.10.5051-5061.2002","article-title":"Strength of envelope protein interaction modulates cytopathicity of measles virus","volume":"76","author":"RK Plemper","year":"2002","journal-title":"J Virol"},{"issue":"13","key":"ppat.1009283.ref024","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00577-19","article-title":"Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes","volume":"93","author":"BG Bradel-Tretheway","year":"2019","journal-title":"J Virol"},{"issue":"16","key":"ppat.1009283.ref025","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1128\/JVI.01210-13","article-title":"The measles virus hemagglutinin beta-propeller head beta4-beta5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule","volume":"87","author":"M Mateo","year":"2013","journal-title":"J Virol"},{"issue":"7","key":"ppat.1009283.ref026","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1128\/JVI.06414-11","article-title":"Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression","volume":"86","author":"B Sawatsky","year":"2012","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009283.ref027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"T Nakamura","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"8","key":"ppat.1009283.ref028","doi-asserted-by":"crossref","DOI":"10.3390\/v11080761","article-title":"Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species","volume":"11","author":"H Fukuhara","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"ppat.1009283.ref029","doi-asserted-by":"crossref","first-page":"e57488","DOI":"10.1371\/journal.pone.0057488","article-title":"Experimental adaptation of wild-type canine distemper virus (CDV) to the human entry receptor CD150","volume":"8","author":"M Bieringer","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ppat.1009283.ref030","doi-asserted-by":"crossref","first-page":"e1007605","DOI":"10.1371\/journal.ppat.1007605","article-title":"Cyclical adaptation of measles virus quasispecies to epithelial and lymphocytic cells: To V, or not to V","volume":"15","author":"RC Donohue","year":"2019","journal-title":"PLoS Pathog"},{"issue":"14","key":"ppat.1009283.ref031","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"BD Anderson","year":"2004","journal-title":"Cancer Res"},{"issue":"8","key":"ppat.1009283.ref032","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/JTO.0000000000000214","article-title":"Measles vaccine strains for virotherapy of non-small-cell lung carcinoma","volume":"9","author":"MR Patel","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"21","key":"ppat.1009283.ref033","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1128\/JVI.74.21.9911-9915.2000","article-title":"Measles virus assembly within membrane rafts","volume":"74","author":"S Vincent","year":"2000","journal-title":"J Virol"},{"issue":"14","key":"ppat.1009283.ref034","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1128\/JVI.76.14.7174-7186.2002","article-title":"Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses","volume":"76","author":"M Moll","year":"2002","journal-title":"J Virol"},{"issue":"9","key":"ppat.1009283.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/v11090800","article-title":"Fusogenicity of the Ghana Virus (Henipavirus: Ghanaian bat henipavirus) Fusion Protein is Controlled by the Cytoplasmic Domain of the Attachment Glycoprotein","volume":"11","author":"K Voigt","year":"2019","journal-title":"Viruses"},{"issue":"22","key":"ppat.1009283.ref036","doi-asserted-by":"crossref","first-page":"11186","DOI":"10.1128\/JVI.76.22.11186-11198.2002","article-title":"Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins","volume":"76","author":"KN Bossart","year":"2002","journal-title":"J Virol"},{"issue":"5","key":"ppat.1009283.ref037","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1099\/jgv.0.000415","article-title":"Morbillivirus and henipavirus attachment protein cytoplasmic domains differently affect protein expression, fusion support and particle assembly","volume":"97","author":"B Sawatsky","year":"2016","journal-title":"J Gen Virol"},{"issue":"9","key":"ppat.1009283.ref038","article-title":"Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer","volume":"19","author":"MH Do","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"ppat.1009283.ref039","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/cgt.2016.22","article-title":"Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy","volume":"23","author":"SL Hulin-Curtis","year":"2016","journal-title":"Cancer gene therapy"},{"issue":"12","key":"ppat.1009283.ref040","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1172\/JCI85856","article-title":"Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells","volume":"126","author":"DW Sherbenou","year":"2016","journal-title":"J Clin Invest"},{"issue":"17","key":"ppat.1009283.ref041","doi-asserted-by":"crossref","first-page":"11763","DOI":"10.1074\/jbc.M800896200","article-title":"Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150)","volume":"283","author":"CK Navaratnarajah","year":"2008","journal-title":"J Biol Chem"},{"issue":"35","key":"ppat.1009283.ref042","doi-asserted-by":"crossref","first-page":"32294","DOI":"10.1074\/jbc.M202973200","article-title":"Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein","volume":"277","author":"C Santiago","year":"2002","journal-title":"J Biol Chem"},{"issue":"23","key":"ppat.1009283.ref043","doi-asserted-by":"crossref","first-page":"13149","DOI":"10.1128\/JVI.01415-07","article-title":"Affinity thresholds for membrane fusion triggering by viral glycoproteins","volume":"81","author":"K Hasegawa","year":"2007","journal-title":"J Virol"},{"issue":"9","key":"ppat.1009283.ref044","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41591-019-0549-5","article-title":"Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR","volume":"25","author":"S Ghorashian","year":"2019","journal-title":"Nat Med"},{"issue":"17","key":"ppat.1009283.ref045","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","article-title":"Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice","volume":"75","author":"X Liu","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"ppat.1009283.ref046","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nm1192","article-title":"Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection","volume":"11","author":"K Morizono","year":"2005","journal-title":"Nat Med"},{"issue":"4","key":"ppat.1009283.ref047","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/10430340150503957","article-title":"Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein","volume":"12","author":"AH Lin","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"2","key":"ppat.1009283.ref048","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/JVI.02419-12","article-title":"Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008","volume":"87","author":"K Sakai","year":"2013","journal-title":"J Virol"},{"key":"ppat.1009283.ref049","article-title":"Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations","author":"MF Leber","year":"2020","journal-title":"J Gen Virol"},{"key":"ppat.1009283.ref050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vetmic.2018.03.014","article-title":"Antigenic analysis of genetic variants of Canine distemper virus","volume":"219","author":"E Anis","year":"2018","journal-title":"Vet Microbiol"},{"issue":"2","key":"ppat.1009283.ref051","doi-asserted-by":"crossref","first-page":"e0192245","DOI":"10.1371\/journal.pone.0192245","article-title":"Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses","volume":"13","author":"MA Munoz-Alia","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"ppat.1009283.ref052","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/mt.2013.164","article-title":"Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread","volume":"21","author":"C Ayala-Breton","year":"2013","journal-title":"Mol Ther"},{"issue":"15","key":"ppat.1009283.ref053","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1128\/JVI.03823-13","article-title":"Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus\/measles virus hybrid VSV-FH a growth advantage over measles virus","volume":"88","author":"C Ayala-Breton","year":"2014","journal-title":"J Virol"},{"issue":"7","key":"ppat.1009283.ref054","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/104303401750148766","article-title":"Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas","volume":"12","author":"E Galanis","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"1","key":"ppat.1009283.ref055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/gt.2011.205","article-title":"Measles virus causes immunogenic cell death in human melanoma","volume":"20","author":"OG Donnelly","year":"2013","journal-title":"Gene Ther"},{"issue":"7","key":"ppat.1009283.ref056","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.cgt.7701055","article-title":"Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment","volume":"14","author":"D Hoffmann","year":"2007","journal-title":"Cancer gene therapy"},{"issue":"37","key":"ppat.1009283.ref057","doi-asserted-by":"crossref","first-page":"15384","DOI":"10.1073\/pnas.1107382108","article-title":"Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells","volume":"108","author":"M Iwasaki","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ppat.1009283.ref058","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ymthe.2018.01.019","article-title":"Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy","volume":"26","author":"JM Ricca","year":"2018","journal-title":"Mol Ther"},{"issue":"138","key":"ppat.1009283.ref059","doi-asserted-by":"crossref","first-page":"138ra77","DOI":"10.1126\/scitranslmed.3003578","article-title":"Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients","volume":"4","author":"RA Adair","year":"2012","journal-title":"Sci Transl Med"},{"issue":"4","key":"ppat.1009283.ref060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/mthe.2000.0133","article-title":"Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model","volume":"2","author":"ES Lambright","year":"2000","journal-title":"Mol Ther"},{"issue":"14","key":"ppat.1009283.ref061","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1158\/1078-0432.CCR-12-3199","article-title":"Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia","volume":"19","author":"DP Conrad","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"8","key":"ppat.1009283.ref062","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1128\/JVI.03676-13","article-title":"Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus","volume":"88","author":"RD de Vries","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009283.ref063","first-page":"133","article-title":"Cell-mediated immunity and age at vaccination associated with measles inoculation and protection of dogs against canine distemper","volume":"37","author":"JD Gerber","year":"1976","journal-title":"Am J Vet Res"},{"issue":"5","key":"ppat.1009283.ref064","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"RT Chen","year":"1990","journal-title":"J Infect Dis"},{"issue":"2","key":"ppat.1009283.ref065","first-page":"e01047","article-title":"Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA","volume":"5","author":"WH Lin","year":"2014","journal-title":"mBio"},{"issue":"6","key":"ppat.1009283.ref066","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/rmv.480","article-title":"Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180\u20131187","volume":"15","author":"A Zingher","year":"2005","journal-title":"Rev Med Virol"},{"issue":"1","key":"ppat.1009283.ref067","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/JVI.70.1.255-263.1996","article-title":"Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells","volume":"70","author":"J Schneider-Schaulies","year":"1996","journal-title":"J Virol"},{"issue":"10","key":"ppat.1009283.ref068","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tim.2015.07.005","article-title":"Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?","volume":"23","author":"M Pelegrin","year":"2015","journal-title":"Trends Microbiol"},{"issue":"4","key":"ppat.1009283.ref069","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/infdis\/168.4.1020","article-title":"Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions","volume":"168","author":"DN Forthal","year":"1993","journal-title":"J Infect Dis"},{"issue":"23","key":"ppat.1009283.ref070","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1158\/1078-0432.CCR-09-1292","article-title":"Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model","volume":"15","author":"EK Mader","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ppat.1009283.ref071","article-title":"Dog nectin-4 is an epithelial cell receptor for canine distemper virus that facilitates virus entry and syncytia formation","author":"RS Noyce","year":"2012","journal-title":"Virology"},{"issue":"9","key":"ppat.1009283.ref072","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1128\/JVI.75.9.4399-4401.2001","article-title":"Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor","volume":"75","author":"N Ono","year":"2001","journal-title":"J Virol"},{"issue":"6798","key":"ppat.1009283.ref073","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"H Tatsuo","year":"2000","journal-title":"Nature"},{"issue":"18","key":"ppat.1009283.ref074","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.1128\/JVI.77.18.9943-9950.2003","article-title":"Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells","volume":"77","author":"F Seki","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"ppat.1009283.ref075","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1128\/JVI.02628-13","article-title":"Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus\/measles virus","volume":"88","author":"YP Liu","year":"2014","journal-title":"J Virol"},{"issue":"7","key":"ppat.1009283.ref076","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood-2002-07-2195","article-title":"Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker","volume":"101","author":"KW Peng","year":"2003","journal-title":"Blood"},{"key":"ppat.1009283.ref077","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virusres.2017.04.018","article-title":"Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies","volume":"236","author":"MA Mu\u00f1oz-Alia","year":"2017","journal-title":"Virus Res"},{"issue":"8","key":"ppat.1009283.ref078","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1128\/JVI.71.8.6144-6154.1997","article-title":"Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding","volume":"71","author":"EC Hsu","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009283.ref079","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JVI.72.2.1224-1234.1998","article-title":"Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence","volume":"72","author":"T Cathomen","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009283.ref080","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00376-16","article-title":"Efficient and Robust Paramyxoviridae Reverse Genetics Systems","volume":"2","author":"SM Beaty","year":"2017","journal-title":"mSphere"},{"issue":"19","key":"ppat.1009283.ref081","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1074\/jbc.M109.067090","article-title":"Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain","volume":"285","author":"N Kondo","year":"2010","journal-title":"J Biol Chem"},{"issue":"12","key":"ppat.1009283.ref082","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/protein\/gzs051","article-title":"Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP","volume":"25","author":"H Ishikawa","year":"2012","journal-title":"Protein Eng Des Sel"},{"key":"ppat.1009283.ref083","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymeth.2015.05.021","article-title":"Using a split luciferase assay (SLA) to measure the kinetics of cell-cell fusion mediated by herpes simplex virus glycoproteins","volume":"90","author":"WT Saw","year":"2015","journal-title":"Methods"},{"issue":"15","key":"ppat.1009283.ref084","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1128\/JVI.78.15.7894-7903.2004","article-title":"Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function","volume":"78","author":"V von Messling","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"ppat.1009283.ref085","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.01669-08","article-title":"Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus","volume":"83","author":"AM Toth","year":"2009","journal-title":"J Virol"},{"issue":"9","key":"ppat.1009283.ref086","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1128\/JVI.72.9.7420-7427.1998","article-title":"Measles virus spread and pathogenesis in genetically modified mice","volume":"72","author":"B Mrkic","year":"1998","journal-title":"J Virol"},{"issue":"11","key":"ppat.1009283.ref087","article-title":"Antigenic Drift Defines a New D4 Subgenotype of Measles Virus","volume":"91","author":"MA Munoz-Alia","year":"2017","journal-title":"J Virol"},{"issue":"27","key":"ppat.1009283.ref088","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","article-title":"A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine","volume":"29","author":"IH Haralambieva","year":"2011","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1009283","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T22:43:26Z","timestamp":1613515406000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009283"}},"subtitle":[],"editor":[{"given":"Alexander","family":"Bukreyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1009283","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1009283","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]}}}